iifl-logo-icon 1

Gland Pharma Ltd Cash Flow Statement

1,459.4
(-1.13%)
Feb 14, 2025|03:31:12 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gland Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2017

Profit before tax

1,619.04

1,334.85

578.01

Depreciation

-110.29

-98.78

-74.14

Tax paid

-406.88

-337.84

-164.28

Working capital

496.99

3,455.68

Other operating items

Operating

1,598.84

4,353.9

Capital expenditure

650.62

425.18

Free cash flow

2,249.46

4,779.08

Equity raised

11,816.64

6,965.1

Investing

162.48

0.55

Financing

9.74

11.38

Dividends paid

0

0

0

Net in cash

14,238.33

11,756.12

Gland Pharma : related Articles

Top Stocks for Today - 4th February 2025
4 Feb 2025|07:20 AM

Here are some of the stocks that may see significant price movement today: Tata Chemicals, Power Grid, Welspun Enterprises, etc.

Read More
Gland Pharma Q3 Profit Rises 6.7% YoY
3 Feb 2025|07:43 PM

EBITDA (Earnings Before Interest, Tax, Depreciation, and Amortization) increased by 1% YoY to ₹360 crore, compared to ₹356.4 crore in the previous year.

Read More
Mankind Pharma inks pact to commercialise Sintilimab in India
27 Dec 2024|09:09 AM

Sintilimab is marketed in China as TYVYT (sintilimab injectable) and was co-developed by Innovent and Eli Lilly.

Read More
Top Stocks for Today - 27th December 2024
27 Dec 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Power Mech, IndiGo, NHPC, Gland Pharma, etc.

Read More
Gland Pharma Sees Q2 Profit Drop, Revenue Rise
5 Nov 2024|10:50 AM

Gland Pharma stock has gained a total of 12% in the last one year, and 7.37% dip since the beginning of the year.

Read More
Top 10 stocks for today – 7th August 2024
7 Aug 2024|08:16 AM

Here are some of the stocks that may see significant price movement today: Tata Power, Chambal Fertilisers, Cummins India, etc.

Read More
Gland Pharma faces FDA inspection, gets 3 observations
5 Aug 2024|11:20 AM

The inspection concluded with three 483 observations. Gland Pharma clarified that these observations are procedural and not related to data integrity or repeat issues.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.